Abstract
HLA-B27 is a cell marker of clinical interest because of its high association with certain diseases. The HLA-B27 antigen was detected on lymphocytes using a monoclonal antibody in an indirect immuno-fluorescence assay using a fluorescence flow cytometer. The considerable crossreaction of the monoclonal antibody with the HLA-B7 antigen was effectively suppressed by masking it by means of human anti-HLA-B7 antiserum. The flow cytometric method was evaluated by comparing the results with those obtained by the standard lymphocytotoxicity test and showed complete agreement in 107 selected patient samples.
References
1.
Svejgaard
A
Platz
P
Ryder
LP
. HLA and disease 1982—A survey . Immunol Rev
1983 ; 70 : 193 –218 .
2.
Terasaki
PI
McClelland
JD
. Microdroplet assay of human serum cytotoxins . Nature
1964 ; 204 : 998 –1000 .
3.
Albrecht
J
Müller
HAG
. HLA-B27 typing by use of flow cytofluorometry . Clin Chem
1987 ; 33 : 1619 –23 .
4.
Fizet
D
Hitte
C
Ferrer
AM
Vezon
G.
Identification de l'antigène HLA B27 par cytométrie de flux . Ann Biol Clin
1989 ; 47 : 408 –11 .
5.
Trapani
JA
Vaughan
HA
Sparrow
RL
Tait
BD
McKenzie
IF
. Description of a mouse monoclonal anti-HLA-B27 antibody HLA-ABC-m3 . Human Immunol
1983 ; 7 : 205 –16 .
6.
Böyum
A.
Separation of leucocytes from blood and bone marrow . Scand J Clin Lab Invest
1968 ; 21 : (suppl. 97 ): 1 –109 .